Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases.
about
Clostridium difficile drug pipeline: challenges in discovery and development of new agentsThe dual topoisomerase inhibitor A35 preferentially and specially targets topoisomerase 2α by enhancing pre-strand and post-strand cleavage and inhibiting DNA religationA "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.In vitro biological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerases.Topoisomerases: Resistance versus Sensitivity, How Far We Can Go?Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis.
P2860
Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biological evaluation of benzo ...... terial type II topoisomerases.
@en
Biological evaluation of benzo ...... terial type II topoisomerases.
@nl
type
label
Biological evaluation of benzo ...... terial type II topoisomerases.
@en
Biological evaluation of benzo ...... terial type II topoisomerases.
@nl
prefLabel
Biological evaluation of benzo ...... terial type II topoisomerases.
@en
Biological evaluation of benzo ...... terial type II topoisomerases.
@nl
P2093
P2860
P356
P1476
Biological evaluation of benzo ...... terial type II topoisomerases.
@en
P2093
Alastair Logan
Carol Smee
Christopher J Lunniss
Daniel Price
David J Haydon
Hilary Peasley
Ian Collins
James M Bennett
Joanne Berry
Lloyd G Czaplewski
P2860
P304
P356
10.1128/AAC.00719-13
P407
P577
2013-09-16T00:00:00Z